查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1766320

獸醫參考實驗室市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Veterinary Reference Laboratory Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 136 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年，全球獸醫參考實驗室市場規模達49億美元，預計到2034年將以10.6%的複合年成長率成長，達到133億美元。這一成長的主要驅動力是農場動物和伴侶動物中慢性病和人畜共患疾病發生率的上升。疾病負擔的增加引發了對診斷服務的需求成長，尤其是隨著寵物主人對糖尿病、癌症和寄生蟲感染等疾病早期診斷意識的不斷增強。在畜牧業，食品安全和動物健康的更嚴格要求進一步鼓勵了先進檢測服務的採用。

獸醫參考實驗室市場 - IMG1

在以改善動物健康管理為核心的監管措施的推動下，公共和私人投資正在推動診斷基礎設施的發展。獸醫診斷實驗室網路的不斷擴大以及診所和參考機構之間日益加強的合作，有助於將服務拓展到先前服務不足的市場。此外，寵物保險覆蓋率的提高，使得寵物主人能夠更經濟地接受獸醫診斷，從而提高了參考實驗室服務的利用率，並加速了已開發經濟體和新興經濟體市場的發展勢頭。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 49億美元
預測值 133億美元
複合年成長率 10.6%

2024年，臨床化學領域的估值達到18億美元，這得歸功於這些檢測在血液和體液分析中所扮演的關鍵角色。這些檢測對於評估內臟器官功能、電解質水平和整體代謝狀態至關重要。它們對於檢測寵物和牲畜的慢性疾病（例如腎臟疾病、糖尿病和內分泌疾病）尤其重要。自動化高通量分析儀在參考實驗室中的應用日益增多，有助於快速提供準確的結果，滿足了日益成長的常規和緊急診斷服務需求。

臨床病理學領域在2024年佔了34.6%的市場佔有率，並將繼續成為獸醫診斷的基石。該領域包括血液學、細胞學、尿液分析和化學檢測等重要服務，有助於識別動物的各種疾病狀況。臨床病理學是獸醫醫療保健的第一線評估，為從常規健康監測到複雜疾病的診斷等各個方面提供幫助。隨著慢性病和傳染病的日益普遍，臨床和預防保健領域對這些檢測在動物健康管理中的依賴性也日益增強。

2024年，美國獸醫參考實驗室市場規模達17億美元。其成長主要得益於高寵物擁有率、不斷成長的獸醫支出以及現代動物照護服務的普及。美國完善的獸醫基礎設施以及寵物保險的廣泛普及，正在鼓勵人們更頻繁地進行診斷檢測。這種環境支持了美國先進參考實驗室服務的擴張，並對整個市場做出了重大貢獻。

全球獸醫參考實驗室市場的主要參與者包括 Zoetis、Heska Corporation、IDEXX Laboratories、Thermo Fisher Scientific、Antech Diagnostics (Mars)、Virbac、Nova Biomedical、Vaxxinova、Boehringer Ingelheim International、Laboklin、GD Animal Health、Neogen Corporation 和科羅拉多州立大學。為了鞏固其在獸醫參考實驗室市場的地位，各公司正在實施一系列策略性措施。這些措施包括擴大實驗室網路並與獸醫診所建立策略合作夥伴關係以提高服務的可及性。許多公司也正在投資下一代診斷工具和自動化，以提供更快、更準確的結果。透過收購和在地化服務開拓新興市場，使他們能夠接觸到更多客戶，同時提高營運的可擴展性。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
    • 供應商格局
    • 每個階段的增值
    • 影響價值鏈的因素
  • 產業衝擊力
    • 成長動力
      • 越來越多人收養寵物作為陪伴
      • 寵物保險普及率上升，動物保健支出增加
      • 寵物中人畜共通傳染病數量不斷增加
    • 產業陷阱與挑戰
      • 診斷服務成本高昂
      • POC攜帶式儀器的需求不斷成長
    • 機會
      • 向新興市場擴張
      • 牲畜和食品安全檢測需求不斷成長
  • 成長潛力分析
  • 監管格局
  • 技術和創新格局
    • 當前的技術趨勢
    • 新興技術
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 關鍵進展
    • 併購
    • 夥伴關係和合作
    • 新產品發布
    • 擴張計劃

第5章：市場估計與預測：按技術，2021 年至 2034 年

  • 主要趨勢
  • 臨床化學
  • 免疫診斷
    • 酵素連結免疫吸附試驗
    • 橫向流動試驗
    • 其他免疫診斷檢測
  • 分子診斷
    • PCR檢測
    • 微陣列
    • 其他分子診斷服務
  • 血液學
  • 尿液分析
  • 其他技術

第6章：市場估計與預測：按應用，2021 年至 2034 年

  • 主要趨勢
  • 臨床病理學
  • 細菌學
  • 病毒學
  • 寄生蟲學
  • 生產力測試
  • 妊娠測試
  • 毒理學測試

第7章：市場估計與預測：依動物類型，2021 年至 2034 年

  • 主要趨勢
  • 伴侶動物
    • 狗
    • 貓
    • 馬匹
    • 其他伴侶動物
  • 牲畜
    • 牛
    • 豬
    • 家禽
    • 綿羊和山羊
    • 其他牲畜

第8章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • Antech Diagnostics
  • Boehringer Ingelheim International
  • Colorado State University
  • GD Animal Health
  • Heska Corporation
  • IDEXX Laboratories
  • Laboklin
  • Neogen Corporation
  • Nova Biomedical
  • Thermo Fisher Scientific
  • Virbac
  • VCA
  • Vaxxinova
  • Zoetis
簡介目錄
Product Code: 5540

The Global Veterinary Reference Laboratory Market was valued at USD 4.9 billion in 2024 and is estimated to grow at a CAGR of 10.6% to reach USD 13.3 billion by 2034. A major driver of this growth is the rising incidence of chronic and zoonotic diseases in farm and companion animals. This increase in disease burden has sparked greater demand for diagnostic services, especially as awareness among pet owners regarding early diagnosis of conditions like diabetes, cancer, and parasitic infections continues to grow. In the livestock industry, stricter requirements around food safety and animal health are further encouraging the adoption of advanced testing services.

Veterinary Reference Laboratory Market - IMG1

Public and private investments, driven by regulatory efforts centered on improving animal health management, are fueling the development of diagnostic infrastructure. Expanding networks of veterinary diagnostic laboratories and growing collaborations between clinics and reference facilities are helping to extend services into previously underserved markets. Additionally, a rise in pet insurance coverage is making veterinary diagnostics more financially accessible to pet owners, enhancing the utilization of reference laboratory services and accelerating the market's momentum across both developed and emerging economies.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$4.9 Billion
Forecast Value$13.3 Billion
CAGR10.6%

In 2024, the clinical chemistry segment achieved a valuation of USD 1.8 billion due to the critical role these tests play in analyzing blood and bodily fluids. These tests are essential for assessing internal organ functions, electrolyte levels, and overall metabolic status. They are particularly relevant for detecting chronic diseases such as renal disorders, diabetes, and endocrine conditions in pets and livestock. The growing use of automated, high-throughput analyzers in reference labs has helped deliver quick and accurate results, meeting the increasing demand for both routine and emergency diagnostic services.

The clinical pathology segment captured a 34.6% share in 2024 and remains a cornerstone of veterinary diagnostics. This category includes vital services like hematology, cytology, urinalysis, and chemistry-based tests that help identify various disease conditions in animals. Clinical pathology serves as the first line of evaluation in veterinary healthcare, aiding in everything from routine health monitoring to diagnosing complex illnesses. With chronic and infectious diseases becoming more common, there is heightened reliance on these tests for managing animal health across both clinical and preventive care settings.

U.S. Veterinary Reference Laboratory Market reached USD 1.7 billion in 2024. Its growth is driven by high pet ownership rates, increasing veterinary expenditures, and strong access to modern animal care services. The country's well-established veterinary infrastructure, along with the widespread adoption of pet insurance, is encouraging more frequent diagnostic testing. This environment supports the expansion of advanced reference laboratory services in the country and contributes significantly to the overall market.

Key players operating in the Global Veterinary Reference Laboratory Market include Zoetis, Heska Corporation, IDEXX Laboratories, Thermo Fisher Scientific, Antech Diagnostics (Mars), Virbac, Nova Biomedical, Vaxxinova, Boehringer Ingelheim International, Laboklin, GD Animal Health, Neogen Corporation, and Colorado State University. To strengthen their position in the veterinary reference laboratory market, companies are implementing a range of strategic initiatives. These include expanding their laboratory networks and entering strategic partnerships with veterinary clinics to boost service accessibility. Many firms are also investing in next-generation diagnostic tools and automation to deliver faster, more accurate results. Emerging markets through acquisitions and localized service offerings, allowing them to reach more customers while enhancing operational scalability.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Technology
    • 2.2.3 Application
    • 2.2.4 Animal type
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Value addition at each stage
    • 3.1.3 Factors affecting the value chain
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing pet adoption for companionship
      • 3.2.1.2 Rising adoption of pet insurance and increasing animal health expenditure
      • 3.2.1.3 Rising number of zoonotic diseases among pet animals
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with diagnostic services
      • 3.2.2.2 Growing demand for POC portable instruments
    • 3.2.3 Opportunities
      • 3.2.3.1 Expansion into emerging markets
      • 3.2.3.2 Increasing demand for livestock and food safety testing
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East and Africa
  • 3.5 Technology and innovation landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Clinical chemistry
  • 5.3 Immunodiagnostics
    • 5.3.1 ELISA
    • 5.3.2 Lateral flow assays
    • 5.3.3 Other immunodiagnostics assays
  • 5.4 Molecular diagnostics
    • 5.4.1 PCR tests
    • 5.4.2 Microarray
    • 5.4.3 Other molecular diagnostic services
  • 5.5 Hematology
  • 5.6 Urinalysis
  • 5.7 Other technologies

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Clinical pathology
  • 6.3 Bacteriology
  • 6.4 Virology
  • 6.5 Parasitology
  • 6.6 Productivity testing
  • 6.7 Pregnancy testing
  • 6.8 Toxicology testing

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Companion animals
    • 7.2.1 Dogs
    • 7.2.2 Cats
    • 7.2.3 Horses
    • 7.2.4 Other companion animals
  • 7.3 Livestock animals
    • 7.3.1 Cattle
    • 7.3.2 Swine
    • 7.3.3 Poultry
    • 7.3.4 Sheep and goats
    • 7.3.5 Other livestock animals

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Antech Diagnostics
  • 9.2 Boehringer Ingelheim International
  • 9.3 Colorado State University
  • 9.4 GD Animal Health
  • 9.5 Heska Corporation
  • 9.6 IDEXX Laboratories
  • 9.7 Laboklin
  • 9.8 Neogen Corporation
  • 9.9 Nova Biomedical
  • 9.10 Thermo Fisher Scientific
  • 9.11 Virbac
  • 9.12 VCA
  • 9.13 Vaxxinova
  • 9.14 Zoetis